Skip to main content
Livermore
Livermore
ZHEN

NexImmune, Inc.

NEXIDelisted Sep 6, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001538210

NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.

Holders of 5% or more of NEXI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NexImmune, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of NexImmune, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

13 Schedule 13D and 13G filings on NexImmune, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NEXI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 7, 2023Barer Sol J13DOld format–––SEC
Feb 15, 2023ArrowMark Colorado Holdings LLC13G/AOld format–––SEC
Feb 13, 2023B&S NexImmune Holdco LLC13G/AOld format–––SEC
Feb 13, 2023Barer Sol J13G/AOld format–––SEC
Feb 13, 2023Artal International S.C.A.13G/AOld format–––SEC
Feb 22, 2022Brady Louise F.13GOld format–New–SEC
Feb 18, 2022Long Robert E. Jr.13GOld format–New–SEC
Feb 14, 2022Piedmont Capital Partners, LLC13GOld format–New–SEC
Feb 14, 2022ArrowMark Colorado Holdings LLC13G/AOld format–––SEC
Feb 11, 2022Barer Sol J13GOld format–New–SEC
Feb 11, 2022B&S NexImmune Holdco LLC13GOld format–New–SEC
Apr 12, 2021ArrowMark Colorado Holdings LLC13GOld format–New–SEC
Mar 31, 2021Artal International S.C.A.13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell NexImmune, Inc. shares.

No Form 144 notices for NexImmune, Inc. are on file.